Drug Shortage Report for ONDANSETRON INJECTION USP
| Report ID | 271238 |
| Drug Identification Number | 02464578 |
| Brand name | ONDANSETRON INJECTION USP |
| Common or Proper name | ONDANSETRON INJECTION USP |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ONDANSETRON |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 VIALS X 2 ML |
| ATC code | A04AA |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2025-10-07 |
| Estimated end date | 2025-12-31 |
| Actual end date | 2025-12-01 |
| Shortage status | Resolved |
| Updated date | 2025-12-03 |
| Company comments | Product is available and on 100% preventative allocation at McKesson. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-12-03 | French | Compare |
| v3 | 2025-12-03 | English | Compare |
| v2 | 2025-11-06 | French | Compare |
| v1 | 2025-11-06 | English | Compare |
Showing 1 to 4 of 4